| Ms Angela Marie Chenier, OTR/L | |
|
1940 W Dickerson St Ste 102, Bozeman, MT 59718-6851 | |
| (406) 555-5555 | |
| Not Available |
| Full Name | Ms Angela Marie Chenier |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1940 W Dickerson St Ste 102, Bozeman, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457510745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1042 (Montana) | Primary |
| Provider Name | Neuro Rehab Associates, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043406168 PECOS PAC ID: 8820159106 Enrollment ID: O20081204000672 |
News Archive
The research team assessed the impact of breastfeeding on elements of the metabolic syndrome in over 2000 randomly chosen children from Denmark and Estonia, aged between 9 and 15.
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
› Verified 9 days ago
| Provider Name | Neuro Rehab, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1740850783 PECOS PAC ID: 7618368473 Enrollment ID: O20220105001387 |
News Archive
The research team assessed the impact of breastfeeding on elements of the metabolic syndrome in over 2000 randomly chosen children from Denmark and Estonia, aged between 9 and 15.
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
› Verified 9 days ago
| Provider Name | Arete Functional Health Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1194455709 PECOS PAC ID: 9032594981 Enrollment ID: O20220914000641 |
News Archive
The research team assessed the impact of breastfeeding on elements of the metabolic syndrome in over 2000 randomly chosen children from Denmark and Estonia, aged between 9 and 15.
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Angela Marie Chenier, OTR/L Po Box 6514, Bozeman, MT 59771-6514 Ph: (406) 548-7436 | Ms Angela Marie Chenier, OTR/L 1940 W Dickerson St Ste 102, Bozeman, MT 59718-6851 Ph: (406) 555-5555 |
News Archive
The research team assessed the impact of breastfeeding on elements of the metabolic syndrome in over 2000 randomly chosen children from Denmark and Estonia, aged between 9 and 15.
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it's coming from a children's hospital.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
› Verified 9 days ago
Danielle Richardson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 704 W Curtiss St Apt 3, Bozeman, MT 59715 Phone: 615-838-7593 | |
Carly L Valentine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 612 E Main St, Suite C, Bozeman, MT 59715 Phone: 406-522-3722 Fax: 406-522-0018 | |
Rebecca Louise Taylor, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Main St, Suite 2, Bozeman, MT 59715 Phone: 406-582-4182 Fax: 406-582-4182 | |
Mrs. Leila Jean Marie Zemke, OTR L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 104 E Main St, Suite 316, Bozeman, MT 59715 Phone: 406-556-8770 | |
Jace Williams, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2632 Catron St, Bozeman, MT 59718 Phone: 866-746-6696 | |
K.lee Subik, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1532 Ellis St, Bozeman, MT 59715 Phone: 406-586-5694 | |
Victoria Lavina Arnold, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 612 E Main St Ste C, Bozeman, MT 59715 Phone: 406-522-3722 Fax: 406-522-0018 |